Fig. 4From: Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysisForest plot of seroconversion proportions (prevalence) regarding the type of vaccine (A) and etiology of immunodeficiency (B) following the second dose of vaccineBack to article page